ArticleScientific reports2025

In silico screening and experimental validation identify riboflavin as an RNA-targeted antiviral against SARS-CoV-2.

Chae-Hong Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.